Publication | Open Access
Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study
15
Citations
34
References
2023
Year
With favorable safety and tolerability, TACE combined with donafenib and PD-1 inhibitors significantly improved PFS, OS, and ORR compared to TACE combined with donafenib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1